$365 Million is the total value of First Light Asset Management, LLC's 52 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 7.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NEO | Buy | NEOGENOMICS INC | $34,090,000 | +27.2% | 3,847,602 | +59.8% | 9.35% | +10.2% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $21,006,000 | +73.9% | 351,741 | -30.1% | 5.76% | +50.6% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $20,055,000 | +11.0% | 1,566,804 | +6.6% | 5.50% | -3.9% |
| ATRC | Buy | ATRICURE INC | $19,616,000 | -15.2% | 1,075,447 | +4.0% | 5.38% | -26.5% |
| ENTL | Buy | ENTELLUS MEDICAL INC | $16,363,000 | +40.1% | 670,904 | +6.0% | 4.49% | +21.3% |
| OMCL | Buy | OMNICELL INC | $15,391,000 | +1.1% | 317,331 | +6.4% | 4.22% | -12.4% |
| LGND | Buy | LIGAND PHARMACEUTICALS INC | $15,332,000 | +77.8% | 111,971 | +76.8% | 4.20% | +53.9% |
| HBIO | Buy | HARVARD BIOSCIENCE INC | $15,308,000 | -0.8% | 4,638,651 | +12.7% | 4.20% | -14.1% |
| IMMU | Sell | IMMUNOMEDICS INC | $15,262,000 | -16.8% | 944,404 | -28.0% | 4.18% | -27.9% |
| MODN | Buy | MODEL N INC | $14,870,000 | +16.8% | 944,125 | +10.9% | 4.08% | +1.1% |
| XNCR | New | XENCOR INC | $14,133,000 | – | 644,764 | +100.0% | 3.88% | – |
| SHPG | Buy | SHIRE PLC | $12,349,000 | +8.3% | 79,607 | +6.9% | 3.39% | -6.2% |
| NVRO | Buy | NEVRO CORP | $10,764,000 | +97.7% | 155,904 | +160.3% | 2.95% | +71.2% |
| CSII | New | CARDIOVASCULAR SYSTEMS INC | $10,518,000 | – | 444,004 | +100.0% | 2.88% | – |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $9,475,000 | +22.4% | 467,646 | +4.9% | 2.60% | +6.0% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $8,337,000 | -11.8% | 596,778 | +6.1% | 2.29% | -23.6% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $7,771,000 | +32.0% | 415,573 | +51.7% | 2.13% | +14.3% |
| HRTX | Buy | HERON THERAPEUTICS INC | $7,488,000 | +17.8% | 413,721 | +5.1% | 2.05% | +2.0% |
| GMED | Sell | GLOBUS MEDICAL INC | $7,252,000 | +36.3% | 176,457 | -1.4% | 1.99% | +18.0% |
| BLUE | Buy | BLUEBIRD BIO INC | $6,739,000 | +36.0% | 37,838 | +4.9% | 1.85% | +17.8% |
| CDXS | Buy | CODEXIS INC | $6,715,000 | +192.7% | 804,224 | +133.1% | 1.84% | +153.6% |
| XENT | Buy | INTERSECT ENT INC | $5,796,000 | +9.3% | 178,896 | +5.1% | 1.59% | -5.4% |
| TLGT | Buy | TELIGENT INC | $5,456,000 | -45.2% | 1,503,127 | +1.3% | 1.50% | -52.5% |
| QDEL | Sell | QUIDEL CORP | $5,198,000 | -3.3% | 119,901 | -2.1% | 1.42% | -16.2% |
| VCYT | Sell | VERACYTE INC | $5,167,000 | -30.0% | 791,337 | -6.0% | 1.42% | -39.4% |
| TECH | Sell | BIO TECHNE CORP | $4,932,000 | +5.5% | 38,071 | -1.5% | 1.35% | -8.6% |
| KTWO | Sell | K2M GROUP HOLDINGS INC | $4,874,000 | -16.5% | 270,758 | -1.6% | 1.34% | -27.7% |
| HSTM | Buy | HEALTHSTREAM INC | $4,854,000 | +4.3% | 209,587 | +5.2% | 1.33% | -9.7% |
| NXTM | Buy | NXSTAGE MEDICAL INC | $4,668,000 | -7.9% | 192,670 | +4.9% | 1.28% | -20.2% |
| LHCG | Buy | LHC GROUP INC | $4,214,000 | -8.1% | 68,807 | +6.4% | 1.16% | -20.4% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $3,455,000 | -3.0% | 23,057 | -1.6% | 0.95% | -16.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $2,783,000 | -6.3% | 31,213 | -2.2% | 0.76% | -18.8% |
| IRIX | Buy | IRIDEX CORP | $2,422,000 | +8.2% | 317,799 | +33.1% | 0.66% | -6.3% |
| STRM | Sell | STREAMLINE HEALTH SOLUTIONS | $2,324,000 | -10.2% | 1,375,044 | -21.9% | 0.64% | -22.3% |
| IBB | Buy | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,273,000 | -4.0% | 21,291 | +200.0% | 0.62% | -16.9% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $2,105,000 | -2.3% | 41,847 | -1.6% | 0.58% | -15.4% |
| ENZ | Buy | ENZO BIOCHEM INC | $1,932,000 | -18.2% | 237,054 | +5.1% | 0.53% | -29.1% |
| PSCH | POWERSHARES S&P SMALLCAP HEALTH CARE ETFetf | $1,703,000 | +6.1% | 17,285 | 0.0% | 0.47% | -8.1% | |
| ALKS | Sell | ALKERMES PLC | $1,616,000 | +5.6% | 29,533 | -1.8% | 0.44% | -8.5% |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,508,000 | +1.1% | 18,241 | 0.0% | 0.41% | -12.3% | |
| LMAT | Sell | LEMAITRE VASCULAR INC | $1,468,000 | -16.2% | 46,119 | -1.5% | 0.40% | -27.4% |
| CELG | Sell | CELGENE CORP | $1,410,000 | -30.2% | 13,512 | -2.5% | 0.39% | -39.5% |
| MGNX | Sell | MACROGENICS INC | $1,398,000 | -50.1% | 73,558 | -51.5% | 0.38% | -56.9% |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $1,315,000 | +3.9% | 7,580 | 0.0% | 0.36% | -10.0% | |
| XBI | SPDR S&P BIOTECH ETFetf | $806,000 | -1.9% | 9,499 | 0.0% | 0.22% | -15.0% | |
| ABBV | ABBVIE | $402,000 | +8.6% | 4,159 | 0.0% | 0.11% | -6.0% | |
| PFE | PFIZER INC | $310,000 | +1.3% | 8,558 | 0.0% | 0.08% | -12.4% | |
| JNJ | JOHNSON AND JOHNSON | $305,000 | +7.4% | 2,183 | 0.0% | 0.08% | -6.7% | |
| DYNT | Buy | DYNATRONICS CORP | $301,000 | +30.3% | 104,379 | +2.3% | 0.08% | +13.7% |
| NVS | NOVARTIS A G | $300,000 | -2.3% | 3,572 | 0.0% | 0.08% | -15.5% | |
| SNY | SANOFI-SYNTHELABO | $289,000 | -13.7% | 6,720 | 0.0% | 0.08% | -25.5% | |
| MRK | MERCK & CO INC | $242,000 | -12.0% | 4,294 | 0.0% | 0.07% | -24.1% | |
| AMGN | Exit | AMGEN INC | $0 | – | -1,105 | -100.0% | -0.07% | – |
| MDCO | Exit | MEDICINES COMPANY | $0 | – | -220,300 | -100.0% | -2.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.